NDPHS PYLL-2 Study On-Line Seminar 14.05.2021

NDPHS PYLL-2 Study On-Line Seminar 14.05.2021

NDPHS PYLL-2 Study on-line Seminar 14.05.2021 BELARUS & NORT-WEST RUSSIA & Northern Dimension (ND) average Preventable premature mortality in Northern Dimension Partnership countries 2003-2017 Mikko Vienonen ([email protected]) Terveyden ja hyvinvoinnin laitos Finnish National Institute for Health & Welfare BELARUS BELARUS 9,5 14.5.2021 2 INTRODUCTION Overview of 10 NDPHS countries’ record on amenable mortality (POTENTIAL YEARS OF LIFE LOST = PYLL) Methods: Preventable premature deaths were described by Potential Years of Life Lost (PYLL). 1. PYLL data consisted of death registers for 2003, 2009, 2013 and 2017; 2. PYLL-rates were age-standardized by using standard OECD population from 1980; 3. PYLL-rates were expressed as sum of lost life years per 100 000 citizens, from the age of death until they would have lived until 70 years of age. Mikko Vienonen/ NCD EG14.5.2021 3 CONTENTS: • BACKGROUND: Why to monitor premature death ? • METHODOLOGY: Definition of PYLL, ICD-10 classification and age-standardization • DATA: Death and population data applied • RESULTS: Quantitative: 1/ International situation now 2/ Development 2003 --> 2017 by 2 countries (BELARUS & NW-RUSSIA) 3/ Loss of human capital by countries Qualitative: 1/ Country specific successes in feedback seminars 2/ Questions for NDPHS on PYLL-monitoring • CONCLUSIONS: What to do and what not to do ? Mikko Vienonen/ NCD EG14.5.2021 4 PART 1: Overview 2003 – 2009 – 2013 – 2017 10 NDPHS countries’ record on amenable/ avoidable mortality (PYLL-2) PYLL: Helps to understand the size of losses in human life = YEARS !!! Life expectancy Mortality rate Incidence of diseases Prevalence of diseases … 88 European core health indicators ECHI etc. etc. Mikko Vienonen/ NCD EG14.5.2021 5 METHODOLOGY Amer Journal of Public Health, Vol 40, 1950 (17-26) Mikko Vienonen/ NCD EG14.5.2021 6 PYLL-definition: Simple calculation “standard expected length of life ” – before which a death is premature 70 A Pavel died of heart attack at age of 55 years years Pavel’s PYLL = 70 -55 = 15 years B = Anna died of alcohol poisoning at age of 28 years Anna’s PYLL = 70 – 28 = 42 years C = Elisabeth died of brain hemorage at age of 71 years Elisabeth’s PYLL = 70 – 71 = 0 years Mikko Vienonen/ NCD EG14.5.2021 7 WHY ARE PREMATURE DEATHS MONITORED AND PYLL IS CALCULATED ? From Haenszel 1950: Mikko Vienonen/ NCD EG14.5.2021 8 EQUATIONS: Calculation of age-standardized PYLL-rate Equations: Age-standardized PYLL=100000/N x (sum a=0 -> L-1 ((L-a) x (da/na) x Na)) Variance PYLL = (100000/N)**2 x (sum a=0 -> L-1 ((L-a)**2 x (Na/na)**2 x (da/na) x (na-da))) 95 % Confidence interval = age-standardized PYLL +/- 1,96 x square-root (variance PYLL) If CI95 % minimum is <0 ==> lower limit = 0 where (L-a) = lost years of dead at time of death in age group a da = number of dead in age-group a na = person years in age-group a Na = a of age-group in the whole standard population N = size of standard population, x is sign of multiplication and/where **2 means into power of 2 Age-groups are 0 yrs, 1-4 yrs, 5-9 yrs, 10-14 yrs, 15-19 yrs, 20-24 yrs, 25-29 yrs, 30-34 yrs, 35-39 yrs, …, 65- 69 yrs. When the target age 70 is reached, the lost years of a dead one (=L-a) by age-groups are 69.5, 67.0, 62.5, 57.5, 52.5, 47.5, 42.5, 37.5, 32.5, 27.5, 22.5, 17.5, 12.5, 7.5, 2.5 As a standard population the OECD 1980 population is applied; 140669, 547645, 700764, 719340, 741611, 710404, 676832, 660553, 546359, 505176, 481914, 473148, 440361, 337337, 336354 Mikko Vienonen/ NCD EG14.5.2021 9 Preventable Causes of Death by WHO Preventable causes (1-28 categories) 19= 'Diseases of circulatory system (I00-I425,I427-I99)’ 20= 'Ischemic heart disease (I20-I25)’ 1 = 'All causes (A00-R99,V01-Y89)' 21= 'Acute myocardial infarction (I21,I22)’ 2 = 'Infectious, parasitic diseases (A00-B99,J65)' 22= 'Cerebrovascular diseases (I60-I69)’ 3 = 'HIV-disease (B20-B24)’ 23= 'Diseases of respiratory system (J00-J64,J66-J99)’ 4 = ’Hepatitis C (B18.2)’ 24= 'Pneumonia & influenza (J09-J18,J849)’ 5 = 'Malignant neoplasms (C00-C97)’ 25= 'Bronchitis, asthma & emphysema (J40-J47)’ 6= 'Malignant neoplasm of colon, rectum, anus (C18-C21)’ 26= 'Diseases of digestive system 7 = 'Malignant neoplasm of trachea, bronchus, lung (C33-C34)’ (K00-K291,K293-K67,K71-K851,K853- K859,K861- 8= 'Malignant neoplasm of female breast (C50)’ K93)’ 10= ‘Malignant neoplasm of stomach (C16.9)’ 27= 'Chronic liver disease and cirrhosis (K73,K74,K76)’ 11= ‘Malignant neoplasm of prostate (C61)’ 12 = ‘Malignant melanoma of skin (C43.9)’ 28= 'Alcohol related diseases and accidental poisoning by 13 = 'Endocrine, nutritional, metabolic diseases (E00-E90)’ alcohol (F10, G312, 14 = 'Diabetes mellitus (E10-E14)’ G621,G721,I426,K292,K70,K852,K860,O354,P043,Q860,X45)' +( 15 = Diseases of blood & blood forming organs (D50-D89)’ G4051 in Finland) 16 = 'Mental disorders (F00,F02,F04-F09,F11-F99)’ 29= 'External causes of injury & poisoning (V01-X44,X46-Y89)’ 17 = 'Dementia, Alzheimers disease (F01,F03,G30,R54)’ 30= 'Land traffic accidents (V01-V89*)’ 18 = 'Other dis. of nervous system & sense organs 31= 'Other land transport accidents (V01-V89*)’ (G00-G29,G31.0-G311,G31.8-G620,G622-G720,G722-H95)‘ 32= 'Accidental falls (W00-W19)’ 33= 'Suicide (X60-X84,Y870)' Preventable causes continuedMikko Vienonen/ … NCD EG14.5.2021 10 Table 1. PYLL-RATES IN 2017 in the ND-countries COUNTRY TOTAL PYLL WOMEN PYLL MEN PYLL BELARUS 8 890 9. 4 377 9. 13 981 9. ESTONIA 4 986 5. 2 712 5. 7 411 5. FINLAND 3 247 4. 2 139 3.* 4 336 4. GERMANY 3 240 3. 2 349 4.* 4 124 3. LATVIA 7 469 8. 4 074 8. 11 227 8. LITHUANIA 6 880 7. 3 708 7. 10 406 7. NORWAY 2 473 1. 1 921 1. 3 001 1. POLAND 5 286 6. 3 029 6. 7 610 6. NW RUSSIA 9 502 10. 5 363 10. 14 267 10. SWEDEN 2 569 2. 1 955 2. 3 159 2. All ND countries 4 618 2 898 6 371 Arithmetic average of ND 10 5454 3163 7952 Mikko Vienonen/ NCD EG14.5.2021 11 PART 2: Overview of the record of amenable mortality of Belarus & North-West Russia Think of the strategic role of: Health Literacy? Healthy Aging? Human Capital ? Mikko Vienonen/ NCD EG14.5.2021 12 ALL CAUSES M & W Progress of amenable mortality BLR-RUS/NW-POL-SWE 25000 and NDPHS population (Potential Years of Life Lost PYLL ) 20000 15000 10000 PYLL / 100.000 / PYLL 5000 0 2003 2009 2013 2017 All NDPHS countries Belarus Russia Poland Sweden Mikko Vienonen/ NCD EG14.5.2021 13 ALL CAUSES WOMEN Progress of amenable mortality BLR-RUS/NW-POL-SWE and NDPHS population (Potential Years of Life Lost PYLL ) 12000 10000 8000 6000 PYLL/100.000 4000 2000 0 2003 2009 2013 2017 All NDPHS countries Belarus Russia Poland Sweden Mikko Vienonen/ NCD EG14.5.2021 14 ALL CAUSES MEN Progress of amenable mortality BLR-RUS/NW-POL-SWE and NDPHS population 35000 (Potential Years of Life Lost PYLL) 30000 25000 20000 15000 PYLL / 100.000 / PYLL 10000 5000 0 2003 2009 2013 2017 All NDPHS countries Belarus Russia Poland Sweden Mikko Vienonen/ NCD EG14.5.2021 15 Diseases of the circulatory system (I00-I99) M & W 8000 Progress of amenable mortality BLR-RUS/NW- POL-SWE and NDPHS population 7000 (Potential Years of Life Lost PYLL ) 6000 5000 4000 PYLL / 100.000 / PYLL 3000 2000 1000 0 2003 2009 2013 2017 All NDPHS countries Belarus Russia Poland Sweden Mikko Vienonen/ NCD EG14.5.2021 16 Diseases of the circulatory system (I00-I99) WOMEN Progress of amenable mortality BLR-RUS/NW- POL-SWE 4000 and NDPHS population 3500 (Potential Years of Life Lost PYLL ) 3000 2500 2000 PYLL / 100.000 / PYLL 1500 1000 500 0 2003 2009 2013 2017 All NDPHS countries Belarus Russia Poland Sweden Mikko Vienonen/ NCD EG14.5.2021 17 Diseases of the circulatory system (I00-I99) MEN 12000 Progress of amenable mortality BLR-RUS/NW- POL-SWE and NDPHS population 10000 (Potential Years of Life Lost PYLL ) 8000 6000 PYLL / 100.000 / PYLL 4000 2000 0 2003 2009 2013 2017 All NDPHS countries Belarus Russia Poland Sweden Mikko Vienonen/ NCD EG14.5.2021 18 Malignant neoplasms / Cancer (C00-C97) M & W Progress of amenable mortality BLR - RUS/NW – SWE - POL and ND population (Potential Years of Life Lost PYLL ) 2500 2000 1500 1000 PYLL/ 100.000 PYLL/ 500 All ND countries Belarus Poland Russia Sweden 0 2003 2009 2013 2017 Akselin otsikko Mikko Vienonen/ NCD EG14.5.2021 19 Malignant neoplasms / Cancer (C00-C97) WOMEN Progress of amenable mortality BLR-RUS/NW-SWE-POL and ND population (Potential Years of Life Lost PYLL ) 1800 1600 1400 1200 1000 800 PYLL/ 100.000 PYLL/ 600 400 All ND countries Belarus Poland Russia Sweden 200 0 2003 2009 2013 2017 Akselin otsikko Mikko Vienonen/ NCD EG14.5.2021 20 Malignant neoplasms / Cancer (C00-C97) MEN Progress of amenable mortality BLR-RUS/NW- SWE-POL and ND population (Potential Years of Life Lost PYLL ) 3000 2500 2000 1500 1000 500 All ND countries Belarus Poland Russia Sweden 0 2003 2009 2013 2017 Mikko Vienonen/ NCD EG14.5.2021 21 External causes of mortality (V01--Y89) M & W Progress of amenable mortality BLR-RUS/NW- POL-SWE 7000 and ND population 6000 (Potential Years of Life Lost PYLL ) 5000 4000 3000 PYLL/100.000 2000 1000 0 2003 2009 2013 2017 All ND countries Belarus Poland Russia Sweden Mikko Vienonen/ NCD EG14.5.2021 22 3000 External causes of mortality (V01--Y89) WOMEN Progress of amenable mortality BLR-RUS/NW- POL-SWE and ND population 2500 (Potential Years of Life Lost PYLL ) 2000 1500 PYLL/100.000 1000 500 0 2003 2009 2013 2017 All ND countries Belarus Poland Russia Sweden Mikko Vienonen/ NCD EG14.5.2021 23 External causes of mortality (V01--Y89) MEN Progress of amenable mortality BLR-RUS/NW- POL-SWE 12000 and ND population (Potential Years

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    44 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us